Groundbreaking Myeloma Research in Iceland

IMF Visits Iceland on First Anniversary of iStopMM Launch

On the first anniversary of its 2016 launch, the IMF met with the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) research team for a status report on this Black Swan Research Initiative®-supported project. Leading myeloma researchers participated in presentations and discussions of trends so far, benchmarks achieved, challenges, and surprises. Also, attendees visited the newly opened iStopMM Clinic, looking ahead at work plans for Year Two — which will include clinical trials. View photographs captured from this past weekend’s meeting.

 

Fall 2017 Edition of Myeloma Today: Clinical Trial Updates and More

The latest edition of Myeloma Today is out with clinical trial updates on Darzalex, Kyprolis, and Xgeva. Learn about the Myeloma Master Class, an IMF advanced training course for leading hematologists from China. Also, read the IMF InfoLine Coordinators’ response to the question, “Is there myeloma in my stem cells that have been harvested for my transplant?" and more.

 

Easy Ways to Give This Holiday Season!

This year, on Tuesday, November 28, 2017, the International Myeloma Foundation is participating in #GivingTuesday, a global day dedicated to giving. You can donate at any time. Also, if you shop online on Black Friday, then do so at amazon.myeloma.org. A portion of your Amazon purchase amount will be donated to the IMF at no added cost to you!

IMF’s San Fernando Valley Support Group Raises More Than $30K

Members of the San Fernando Valley Myeloma Support Group crowdfunded almost $30,000 in support of the IMF’s 11th Annual Comedy Celebration this year, securing their spot as an Emerald Sponsor for the event. For the past several years, the group, led by myeloma patient Malcolm Katz, has conducted an email campaign asking friends and family to contribute toward the Annual Comedy Celebration. We thank the San Fernando Valley Group for giving back to the IMF in such a profound and impactful way!

First Finnish Patient & Family Seminar Is a Success!

The first Patient & Family Seminar in Finland was held in Helsinki from October 28-29, 2017, to an audience of 200 participants. Dr. Raija Silvennoinen, IMWG member, led the meeting and panel discussion. Guest speaker Dr. Rafat Abonour (Simon Cancer Center, Indiana University) presented on the "Novel Therapies in the Treatment of Multiple Myeloma.” The IMF and the Finnish support group Suomen Syöpäpotilaat ry’s first meeting was just the beginning to many more successful collaborations.

Can a blood test be used to test for minimal residual disease (MRD)? 

In this week’s video, Dr. Brian G.M. Durie explains how Next Generation Flow testing is sensitive enough to detect one myeloma cell in a one million cells.

This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology